Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease

Table 3 The levels of betatrophin, angiopoietin-like protein 3, and lipoprotein lipase were compared between the two coronary heart disease groups after stratification according to Gensini integral

	Groups	n	Betatrophi (pg/mL)	ANGPTL3 (ng/mL)	LPL (ng/mL)
Kazakh	Gensini ≤ 24	32	356.86 ± 58.61	2.34 ± 0.57	50.22 ± 12.27
	25 ≤ Gensini < 53	22	380.03 ± 61.56	3.56 ± 1.03	57.59 ± 10.41
	Gensini ≥ 53	18	452.74 ± 62.241,2	5.94 ± 1.461,2	59.35 ± 13.191,2
Han	Gensini ≤ 24	35	326.07 ± 50.56	2.00 ± 1.32	50.16 ± 13.483
	25 ≤ Gensini < 53	21	369.64 ± 53.44	3.33 ± 0.83	54.39 ± 12.333
	Gensini ≥ 53	9	422.39 ± 59.141	5.19 ± 1.211	57.60 ± 12.351

¹Comparison between mild and moderate within the group (P < 0.05).

²Compared with Han CHD group (P < 0.05).

³Compared with Han CHD group (P > 0.05).

Angiopoietin-like protein 3; LPL: Lipoprotein lipase.